SAB Biotherapeutics, Inc. (SABS)
NASDAQ·Healthcare·Biotechnology
$3.41
-0.44%
Mkt Cap $36.13M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (8 analysts)
$11.33
Range $10.00 – $13.00
Implied Upside
+232.7%
Consensus $11.33 vs current $3.41
NASDAQ·Healthcare·Biotechnology
$3.41
-0.44%
Mkt Cap $36.13M
Buy
5
Hold
0
Sell
0
Price Target (8 analysts)
$11.33
Range $10.00 – $13.00
+232.7%
Consensus $11.33 vs current $3.41